Joseph P. Schwartz, Managing Director
Mr. Schwartz covers biotechnology and was named #1 Stock Picker for Pharmaceuticals in the 2011 FT/StarMine Analyst Awards. In 2010, he earned the Wall Street Journal’s #1 ranking for biotech stock picking as part of its “Best on the Street” analysts survey, which topped his #2 ranking in the Journal’s 2008 “Best on the Street” rankings.
Joseph Schwartz joined Leerink Swann’s biotechnology team in 2003. Before that, he provided economic and strategic consulting services to biotechnology and pharmaceutical companies with Charles River Associates. Earlier in his career, Mr. Schwartz held equity research positions at SG Cowen, State Street Research, and JP Morgan, where he analyzed the fundamental performance drivers of investments in the health care, retail, consumer, media, and entertainment sectors.
Mr. Schwartz received his MBA from Babson College and his BA in economics from Colby College.